Global N-acetylaspartate Concentration in Benign and Non-Benign Multiple Sclerosis Patients of Long Disease Duration

BACKGROUND AND OBJECTIVE: To examine whether clinically benign multiple sclerosis patients (BMS) show similar losses of their global N-acetylaspartate (NAA) neuronal marker relative to more clinically disabled patients of similar disease duration. METHODS: The whole-brain NAA concentration (WBNAA) w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Achtnichts, Lutz, Gonen, Oded, Rigotti, Daniel J, Babb, James S, Naegelin, Yvonne, Penner, Iris-Katharina, Bendtfeld, Kerstin, Hirsch, Jochen, Amann, Michael, Kappos, Ludwig, Gass, Achim
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825814/
https://ncbi.nlm.nih.gov/pubmed/24041438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejrad.2013.08.037
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg